“Expansion of Immuno-Oncology and Cell-Based Therapies”
A major trend in the Medical Gas market is the expansion of immuno-oncology and cell-based therapies such as CAR-T, which are transforming cancer treatment protocols
Rising investments by biotech companies in immune checkpoint inhibitors and genetically engineered T-cell therapies are driving long-term growth
For example, the growing number of clinical trials in CAR-T cell therapies across North America and Asia-Pacific signifies sustained innovation in personalized cancer treatment
